Progression to cancer in patients with confirmed dysplasia compared to dysplasia downgraded to non-dysplastic metaplasia in Barrett’s esophagus: a retrospective cohort study in Sweden
Long-term risk of progression to cancer did not differ between patients with confirmed LGD and IND. These findings suggest that patients with IND should undergo similar management as patients with LGD.
Authors
- Bengt Håkanson (ORCID: https://orcid.org/0000-0003-3368-4878)
- Fredrik Klevebro (ORCID: https://orcid.org/0000-0002-1695-4103)
- Anders Thorell (ORCID: https://orcid.org/0000-0001-7238-1728)
- Mats Lindblad (ORCID: https://orcid.org/0000-0003-3575-6986)
- Åke Öst
- Peter Elbe
- Lennart Mellbom
Institutions
- Synlab Czech (Czechia) (CZ)
- Karolinska University Hospital (SE)
- Danderyds sjukhus (SE)
- Karolinska Institutet (SE)
- Region Blekinge (SE)
- Karlstad Central Hospital (SE)
Publication Details
- Journal
- Clinical Endoscopy
- Published
- 2024-11-25
- DOI
- https://doi.org/10.5946/ce.2023.313
- Citations
- 3
- Primary Topic
- Esophageal Cancer Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.72